Navigation Links
Hip surgery success partially predicted by number of other existing conditions
Date:4/1/2010

Hip fractures are the second leading cause of hospitalization of elderly patients. In many cases, a hip fracture is the first step in a complete decline in the patient's health, setting off a long list of potential complications. According to a new study published in the April 2010 issue of The Journal of Bone and Joint Surgery (JBJS), a person's pre-surgical health classificationas determined by the American Society of Anesthesiologists (ASA)-is a leading indicator as to how well the person will fare after surgery to repair the hip fracture.

The purpose of the study was to define the complications after hip fracture surgery in a single health care system and identify care practices that may lead to improved outcomes in elderly patients with hip fractures.

"We found that the return to the best quality of life after hip surgery is not determined by the type of operation but rather by the patient's pre-existing conditions and complications after surgery," stated Derek Donegan, MD, study co-author and orthopaedic surgery resident at the Hospital of the University of Pennsylvania in Philadelphia. "It is also important to note that the patient's recovery was improved by a team approach of medical specialists, including geriatricians and physiatrists."

The ASA classification system represents the anesthesiologist's assessment of the general health and well-being of the patient before surgery. Typically, there are five classes:

  1. normal healthy patient
  2. patient with mild systemic disease
  3. patient with serious, non-incapacitating systemic disease
  4. patient with life-threatening incapacitating systemic disease
  5. patient that is near death.

The study consisted of a record review of 197 patients over age 65 who underwent hip fracture surgery from 2004 to 2008 treated by the Hospital of the University of Pennsylvania Orthopaedic Trauma and Fracture Service.

The study revealed:

  • Medical complications were more common in patients in ASA class 3 and class 4 than in those in class 2.
  • Patients in ASA class 3 had a 3.78 times greater chance of having a medical complication following surgery than those in class 2.
  • Patients in ASA class 4 had a 7.39 times greater chance of having medical complications following surgery than those in class 2.
  • No significant relationship was identified between the ASA class and surgical complications.

"We confirmed use of the ASA classification can help identify high-risk patients," continued Dr. Donegan. "We recommend these higher risk patients, in class 3 or 4, be closely managed medically so that any existing conditions can be treated and any evolving medical issues can be addressed in a timely manner," continued Dr. Donegan.

Dr. Donegan added, "Utilizing strategies that improve bone health and prevent hip fractures are ways to limit the significant impact a fall can have."


'/>"/>

Contact: Lauren Pearson
pearson@aaos.org
847-384-4031
American Academy of Orthopaedic Surgeons
Source:Eurekalert

Related medicine news :

1. Patients with mild gallstone pancreatitis can undergo surgery sooner, shortening hospital stays
2. Murtha Gallbladder Removal Complications Underscore Risk of Common Surgery
3. Plastic Surgery Website Design Firm Rosemont Media Heads to Miami for the 44th Annual Baker Gordon Symposium
4. Surgery on beating heart thanks to robotic helping hand
5. Mass. Eye and Ear Infirmary Cataract Surgery Trainer teaches residents cataract surgery
6. Study Finds Ponseti Method of Clubfoot Correction Leads to Lower Surgical Rates and Less Revision Surgery
7. SILS -- A New Houston Weight Loss Surgery -- Single Incision Laparoscopic Surgery
8. Lodewijk de Vink Elected to Board of Focused Ultrasound Surgery Foundation
9. Injections May Boost Knee Surgery Success
10. Four-Year-Old Heart Surgery Patient to Lead Thousands as Grand Marshal of Important Fundraising Event for Maria Fareri Childrens Hospital at Westchester Medical Center
11. Society More Open Than Ever About Cosmetic Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... ... February 22, 2017 , ... ... newest advanced absorption cannabidiol (CBD) serum, “NANOCALM 300” Microemulsified Hemp Extract. This ... instant absorption from the mouth into the bloodstream. Far outpacing the ...
(Date:2/22/2017)... ... 22, 2017 , ... The Centers for Medicare & Medicaid ... in Delaware, New Jersey, Pennsylvania and West Virginia prepare for and participate in ... Act of 2015 (MACRA). , This technical assistance, authorized and funded under ...
(Date:2/22/2017)... NJ (PRWEB) , ... February 22, 2017 , ... ... healthcare communications company, launched a new media platform connecting healthcare technology professionals and ... will be followed by a quarterly publication starting on March 1, announced Michael ...
(Date:2/22/2017)... ... February 22, 2017 , ... Pet obesity in the U.S. continued ... according to the Association for Pet Obesity Prevention (APOP). During the ninth annual survey, ... such as the benefits of corn and grains, value of raw and organic diets, ...
(Date:2/22/2017)... ... February 22, 2017 , ... ... so many different solutions on the market, it is easy to start feeling ... Premier Locksmith offers a complimentary security consultation. , Home Security Hardware Choices, ...
Breaking Medicine News(10 mins):
(Date:2/22/2017)... , Feb. 22, 2017 Henry ... an exclusive distribution agreement with Rijuven, which develops ... diagnostic device to medical practitioners. ... electrocardiogram (ECG) and heart sound signals, transmits real-time ... and offers cloud-based analysis to help physicians provide ...
(Date:2/22/2017)... Calif. , Feb. 22, 2017  Bioness, Inc., ... therapies, today announced the first series of successful StimRouter ... at Radboud University Medical Center (Nijmegen, Netherlands ... ( Cork, Ireland ), and Kliniek Park ... the successful launch continuing, Bioness plans to further support ...
(Date:2/22/2017)... , Feb. 22, 2017 Oncternal Therapeutics, ... for both rare and common malignancies, today announced ... financing. The company intends to use the proceeds ... TK216, and to advance preclinical development of a ... Cirmtuzumab is a first-in-class anti-ROR1 monoclonal antibody being ...
Breaking Medicine Technology: